Table 1. P values testing whether one of... | American Society of Hematology

Table 1.

P values testing whether one of the 3 patient groups is different from the others

Test performed	P
Test performed	Baseline	After HIV	Difference
% CD4⁺/CCR5⁺	.98	.94	.16
% CD4⁺/CXCR4⁺	.22	.34	.11
CCR5 MFI on PBMCs	.78	.69	.40
CXCR4 MFI on PBMCs	.57	.99	.40
CD4 MFI on PBMCs	.58	.78	.30
CD28 MFI on CD28⁺/CD152⁺	.39	.59	.33
CD152 MFI on CD28⁺/CD152⁺	.58	.27	.42
% CD28⁺/CD4⁺	.69	.44	.21
% CD152⁺/CD4⁺	.29	.58	.50
CD28 MFI on PBMCs	.22	.81	.22
CD152 MFI on PBMCs	.16	.98	.70
% cocktail⁻/HLADR⁻	.37	.47	.55
% myeloid DC	.79	.79	.58
% plasmacytoid DC	.58	.37	.98
HLADR MFI on PBMCs	.61	.78	.22
HLADR MFI on CD11c⁺/HLADR⁺/cocktail⁻	.24	.19	.74
HLADR MFI on CD11c⁻/HLADR⁺/cocktail⁻	.16	.40	.17
% CD91⁺/CD11c⁺ on HLADR⁺	.58	.69	.87
% CD91⁺/CD11c⁻ on HLADR⁺	.67	.23	.94
CD91 MFI on CD11c⁺/HLADR⁺/cocktail⁻	.28	.08	.78
CD91 MFI on CD11c⁻/HLADR⁺/cocktail⁻	.74	.67	.87
CD91 MFI on PBMCs	.01^*	.23	.22

Test performed	P
Test performed	Baseline	After HIV	Difference
% CD4⁺/CCR5⁺	.98	.94	.16
% CD4⁺/CXCR4⁺	.22	.34	.11
CCR5 MFI on PBMCs	.78	.69	.40
CXCR4 MFI on PBMCs	.57	.99	.40
CD4 MFI on PBMCs	.58	.78	.30
CD28 MFI on CD28⁺/CD152⁺	.39	.59	.33
CD152 MFI on CD28⁺/CD152⁺	.58	.27	.42
% CD28⁺/CD4⁺	.69	.44	.21
% CD152⁺/CD4⁺	.29	.58	.50
CD28 MFI on PBMCs	.22	.81	.22
CD152 MFI on PBMCs	.16	.98	.70
% cocktail⁻/HLADR⁻	.37	.47	.55
% myeloid DC	.79	.79	.58
% plasmacytoid DC	.58	.37	.98
HLADR MFI on PBMCs	.61	.78	.22
HLADR MFI on CD11c⁺/HLADR⁺/cocktail⁻	.24	.19	.74
HLADR MFI on CD11c⁻/HLADR⁺/cocktail⁻	.16	.40	.17
% CD91⁺/CD11c⁺ on HLADR⁺	.58	.69	.87
% CD91⁺/CD11c⁻ on HLADR⁺	.67	.23	.94
CD91 MFI on CD11c⁺/HLADR⁺/cocktail⁻	.28	.08	.78
CD91 MFI on CD11c⁻/HLADR⁺/cocktail⁻	.74	.67	.87
CD91 MFI on PBMCs	.01^*	.23	.22

The table shows P values calculated to observe whether any of the 3 groups is different from the others. The first column in the table compares group 1 with groups 2 and 3 at baseline, and the second column compares them after exposure to Ba-L. The final column compares the median differences among all 3 groups, before and after Ba-L HIV-1 (Kruskal-Wallis, one-sided test of variance). Because of the controversy surrounding the significance of 2-LTR circles, we performed significance tests on those who were called true LTNPs (group 1) versus those who had chronic suppression on HAART (groups 2 and 3 combined). No statistically significant differences in markers other than CD91 were observed.

MFI indicates mean fluorescence intensity.

View Large

This Feature Is Available To Subscribers Only